Korro Bio Stock (NASDAQ: KRRO) stock price, news, charts, stock research, profile.
Open | $44.32 |
Close | $45.09 |
Volume / Avg. | 73.73K / 82.97K |
Day Range | $43.28 - $46.98 |
52 Wk Range | 14.00 - 97.91 |
Market Cap | $419.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 3.99% |
Days to Cover | 5.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Korro Bio (NASDAQ:KRRO) through any online brokerage.
Other companies in Korro Bio’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Altimmune (NASDAQ:ALT), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
Korro Bio has a consensus price target of $123.75.
The stock price for Korro Bio (NASDAQ: KRRO) is $45.09 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Korro Bio.
Korro Bio’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for Korro Bio.
Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.